Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing
855
MEMORANDUM in Support re #854 MOTION in Limine No. 10: Exclude Evidence Related to Roche's Antitrust Allegations filed by Amgen Inc.. (Attachments: #1 Appendix A)(Gottfried, Michael)
<![CDATA[
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Doc. 855 Att. 1
Case 1:05-cv-12237-WGY
Document 855-2
Filed 08/21/2007
Page 1 of 3
APPENDIX A
Roche Proposed Exhibit Number
Document Identification/BatesLabel
Document Description
Exhibit to Roche's Opposition To Amgen's Motion For Summary Judgment On the Antitrust And State Law Counterclaims Exhibit 1
Roche Preliminary Deposition Designations List Roche Preliminary Deposition Designations Roche Preliminary Deposition Designations List
Sharer Ex. 11
Amgen at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Transcript 7:1-8, 10:10-17, 13:6-18, 14:1415:15, 31:20-32:5, 36:8-15, 36:1622, 45:1-23, 47:12-20, 55:9-15, 81:15-18 13:1-4, 121:4-16; 123:13-124:7, 124:8-132:4, 234:2-16, 234:11-16, 379:2-21, 379:22-380:5, 387:4387:13 Mircera WAC Pricing and Contracting Strategies Review Meeting PEG-EPO War Game Debrief, Global Marketing/Competitive Intelligence Email from Torley to Azelby re Jim Follow-up Discounts to Create Cost Recovery Advantage 2007 - 2009 Epogen Plan Strategic Direction Epogen/Aranesp Non Onc 2007-09 Revenue Plan Update CRB Presentation
March 9, 2007 excerpts of deposition transcript of Maureen Michael March 20, 2007 excerpts of deposition transcript of Helen Torley R10-004974841R10-004975230 AM44 0087234AM44 0087267 AM44 0715533AM44 0715534 AM44 1440662AM44 1440694 AM44 0216383AM44 0216441 AM44 1951328AM44 1951333 AM44 0007126AM44 0007166
Exhibit 3
Exhibit 4
Roche Proposed Exhibit 5795 Roche Proposed Exhibit 6110 Roche Proposed Exhibit 3908 Roche Proposed Exhibit 3603 Roche Proposed Exhibit 2278 Roche Proposed Exhibit 4034 Roche Proposed Exhibit 3347
Exhibit 9
Exhibit 13
Exhibit 17 Exhibit 18 Exhibit 19 Exhibit 24 Exhibit 26
Dockets.Justia.com
Case 1:05-cv-12237-WGY
Document 855-2
Filed 08/21/2007
Page 2 of 3
Roche Proposed Exhibit 6534 Roche Proposed Exhibit 3583 Roche Preliminary Deposition Designations List Roche Proposed Exhibit 3884 Roche Preliminary Deposition Designations List Roche Proposed Exhibit 5900
AM44 0664015AM44 0664020 AM44 0392145AM44 0392211 March 27, 2007 excerpt of deposition transcript of Kevin Sharer AM44 1027895AM44 1027896 April 2, 2007 excerpt of deposition transcript of Leslie Mirani AM44 0231755AM44 0231777
Memo from Bleil to Torley re Recap of Strategic Planning Session Developing a Broader and Bolder Partnership with 76:19-79:6, 79:21-80:4, 82:5-22,
Exhibit 54 Exhibit 57 Exhibit 61
Email from Rath to Morrow and Torley re Summary of Discussion with Fresenius 9:13-79, 30:9-31:8, 157:22-158:2, 164:16-:19
Exhibit 63
Exhibit 67
NACO Operating Review Storyboard
Exhibit 68
Roche Preliminary Deposition Designations List Roche Preliminary Deposition Designations List Roche Proposed Exhibit 6417 Roche Proposed Exhibit 7026
March 27, 2007 excerpt of deposition transcript of Tracey Mooney April 2, 2007 excerpt of deposition transcript of Dennis Kogod AM44 0188476AM44 0188516 FMCNA 000001FMCNA 000047
17:10-13, 17:24-18:2, 18:20-19:7, 19:18-20:16, 21:4-22:14, 21:15-22, 23:3-24:3, 43:7-12, 61:5-11
Exhibit 72
Exhibit 73
Qualitative Research - Product X in CKD Sourcing & Supply Agreement No. 200600447 by Amgen, Inc. and Fresenius Medical Care Holdings, Inc.
Exhibit 75 Exhibit 76
Roche Proposed Exhibit 2457
AM44 0095167AM44 0095175
Amgen Achievement Agreement (AAA) Contract
Exhibit 100
Case 1:05-cv-12237-WGY
Document 855-2
Filed 08/21/2007
Page 3 of 3
Roche Proposed Exhibit 6834 Roche Proposed Exhibit 2464 Roche Proposed Exhibit 2696 Roche Proposed Exhibit 3302 Roche Proposed Exhibit 4860 Roche Proposed Exhibit Roche Proposed Exhibit 7306 Roche Proposed Exhibit 2700 Roche Proposed Exhibit 3065 Roche Proposed Exhibit 5901 Roche Preliminary Deposition Designations List Roche Proposed Exhibit 5911 Roche Proposed Exhibit 3410 Roche Proposed Exhibit 4033
AM44 0019536AM44 0019596 AM44 0095176AM44 0095180 AM44 0123862 AM44 0393892AM44 0393909 AM44 1532833AM44 1532857 AM44 0192555AM44 0192573 AM44 0192047AM44 0192078 AM44 0230289AM44 0230328 R000231067R000231073 AM44 0231710AM44 0231732
S2 Hospital Contract Training, July 2004 Amgen Disproportionate Share Hospital (DSh) Program Aranesp Freedom of Less Frequent Dosing Contracted Hospital Q1 2006 Metric Report Hospital Purchasing Agreement by and Between Amgen and City of Hope National Medical Center US Nephrology Business Unit Competitive Response Plan SLOT War Game Follow Up Commercial Analytics Aranesp Strategic Direction and Key Initiatives CERA Dialysis Launch Strategy/POA Outline NACO Operating Review Storyboard
Exhibit 101 Exhibit 102 Exhibit 103 Exhibit 104 Exhibit 106
Exhibit 111 Exhibit 129 Exhibit 142 Exhibit 157 Exhibit 169 Exhibit 178
March 22, 2007 15:24-16:11, 22:15-25, 25:15-18, excerpts of deposition 30:18-31:3, 33:21-34:9, 34:3-16, transcript of Anthony 35:2-11, 41:22-43:6 Messana AM44 0009433AM44 0009452 AM44 1948561AM44 1948563 AM44 0145693AM44 0145754 NBU Update DaVita Draft Term Sheet EPOGEN/ARANESP Dialysis 2004-2006 US Brand Plan
Exhibit 193 Exhibit 209 Exhibit 216
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
